Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

10.60
Delayed Data
As of Jan 20
 0.00 / 0.00%
Today’s Change
6.00
Today|||52-Week Range
13.45
-12.76%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close10.60
Today’s open10.65
Day’s range10.40 - 10.75
Volume201,979
Average volume (3 months)329,368
Market cap$429.5M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-136.59%
Earnings growth (this year)+77.32%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-38.95%
P/E ratioNM
Price/Sales14.17
Price/Book6.12

Competitors

 Today’s
change
Today’s
% change
CRHMCRH Medical Corp+0.05+0.85%
KPTIKaryopharm Therapeut...-0.08-0.76%
AVDLAvadel Pharmaceutica...+0.40+4.04%
COLLCollegium Pharmaceut...+0.19+1.29%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateFebruary 7, 2017
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$28.7M
Annual profit (last year)-$37.5M
Net profit margin-130.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Barabari Sharon A. Surrey
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs